Patents by Inventor Ferda Cevikbas

Ferda Cevikbas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MrgprX2 Antagonists for the Treatment of Inflammatory Disorders
    Publication number: 20250057816
    Abstract: The present disclosure is directed to use of MrgprX2 antagonists in the treatment of inflammatory disorders, e.g., inflammatory disorders of the skin. This invention is also directed to pharmaceutical compositions comprising a MrgprX2 antagonist and a pharmaceutically or orally acceptable carrier for administration.
    Type: Application
    Filed: October 22, 2024
    Publication date: February 20, 2025
    Inventors: Ferda Cevikbas, Ashley Jarvis, Laura Gleave, Nina Connelly Ursinyova, Ricky Cain, Wei Tsung Yau
  • METHOD FOR TREATMENT OF MODERATE TO SEVERE ATOPIC DERMATITIS
    Publication number: 20250002592
    Abstract: The present disclosure relates to use of an anti-IL-13R?1 antibody (such as eblasakimab) or a binding fragment thereof and pharmaceutical formulations comprising same to treat patients with atopic dermatitis (such as lesional atopic dermatitis) including a patient population that received prior treatment with dupilumab, for example to stimulate disease modification.
    Type: Application
    Filed: September 27, 2022
    Publication date: January 2, 2025
    Inventors: Alison Ward, Ferda Cevikbas, Karen Veverka
  • MrgprX2 Antagonists for the Treatment of Inflammatory Disorders
    Publication number: 20230029266
    Abstract: The present disclosure is directed to use of MrgprX2 antagonists in the treatment of inflammatory disorders, e.g., inflammatory disorders of the skin. This invention is also directed to pharmaceutical compositions comprising a MrgprX2 antagonist and a pharmaceutically or orally acceptable carrier for administration.
    Type: Application
    Filed: November 5, 2020
    Publication date: January 26, 2023
    Inventors: Ferda Cevikbas, Ashley Jarvis, Laura Gleave, Nina Connelly Ursinyova, Ricky Cain, Wei Tsung Yau
  • MrgprX2 Antagonists and Uses Thereof
    Publication number: 20230027929
    Abstract: The present disclosure is directed to use of MrgprX2 antagonists in the treatment of inflammatory disorders, e.g., inflammatory disorders of the skin. This invention is also directed to pharmaceutical compositions comprising a MrgprX2 antagonist and a pharmaceutically or orally acceptable carrier for administration.
    Type: Application
    Filed: November 5, 2020
    Publication date: January 26, 2023
    Inventors: Ferda Cevikbas, Christopher Pearson, Donnya Etheridge, Laura Gleave, Mark Duggan, Nina Connelly Ursinyova, Vasileios Roumpelakis
  • MrgprX2 Antagonists and Uses Thereof
    Publication number: 20230002336
    Abstract: The present disclosure is directed to use of MrgprX2 antagonists in the treatment of inflammatory disorders, e.g., inflammatory disorders of the skin. This invention is also directed to pharmaceutical compositions comprising a MrgprX2 antagonist and a pharmaceutically acceptable carrier for topical or oral administration.
    Type: Application
    Filed: November 5, 2020
    Publication date: January 5, 2023
    Inventors: Ferda Cevikbas, Christopher Pearson, Laura Gleave, Nina Connelly Ursinyova